<DOC>
	<DOCNO>NCT02823743</DOCNO>
	<brief_summary>The aim study examine whether treatment 75 mg aspirin daily compare placebo could reduce risk new miscarriage . The treatment start pregnancy detect transvaginal ultrasound ( around gestational week 6+ ) continue week 35/36 . The study single center , randomize , placebo-controlled , double blind stratify age . 400 participant diagnosis idiopathic recurrent abortion enrol , 200 arm aspirin / placebo .</brief_summary>
	<brief_title>RECAB-ASA ; Treatment Recurrent Abortion With Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>recurrent abortion ( ≤ 3 consecutive abortion first trimester ) unknown etiology workup willingness randomize previous participation study know cause recurrent abortion , require specific management age ≥ 40 BMI 35 IVF pregnancy reason IVF recurrent spontaneous abortion ongoing treatment aspirin reason Sjoegren syndrome</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>recurrent pregnancy loss , Habitual abortion</keyword>
</DOC>